Dynamics of Viral Hepatitis Incidence in Uzbekistan
Keywords:
Viral hepatitis, Uzbekistan, epidemiology, hepatitis A, hepatitis B, hepatitis C, public health, vaccination, disease dynamics, healthcare policy.Abstract
This article examines the dynamics of viral hepatitis incidence in Uzbekistan over recent decades. By analyzing epidemiological data, the study highlights trends in the prevalence of hepatitis A, B, C, and E, as well as the effectiveness of national immunization programs and public health initiatives. The results reveal a significant decline in hepatitis A and B incidence following expanded vaccination efforts, while hepatitis C remains a concern due to limited screening and treatment access. The study emphasizes the need for improved diagnostic coverage, public awareness, and continued investment in prevention strategies to mitigate the burden of viral hepatitis in Uzbekistan.
Downloads
References
1. Khamzaeva, N. T., & Saidkasimova, N. S. (2023). The effectiveness of a new food substance-a hard gelatin capsule-«vizion junior» is being studied in children who have recovered from the coronavirus. world Bulletin of Public Health, 20, 41-45.
2. Mirtazayev, О. М., Briko, N. I., Matnazarova, G. S., Saidkasimova, N. S., Toshboev, B. Y., & Khamzaeva, N. T. (2020). SCIENTIFIC, METHODOLOGICAL AND ORGANIZATIONAL BASES OF MANAGEMENT OF THE EPIDEMIC PROCESS IN CASE OF SALMONELLOUS INFECTION IN UZBEKISTAN. Central Asian Journal of Pediatrics, 2020(3), 5-14.
3. Saidkasimova, N. S., Mirtazaev, O. M., Matnazarova, G. S., Toshbaev, B. Y., & Khatamov, A. H. (2021). Epidemiological and Epizootological Characteristics of Salmonellosis and Improvement of Their Epidemiological Control. JournalNX, 610-618.
4. Saidkasimova, N. S., Matnazarova, G. S., & Mirtazayev, O. M. (2018). Some epidemiological patterns of salmonellosis in Uzbekistan. Biology and Medical problems, 4, 95-96.
5. Tajibayeva, D. A., Saidkasimova, N. S., & Xamzayeva, N. T. (2025). O ‘tkir yuqumli ichak infektsiyalari epidemiologik xususiyatlari va ularning epidemiologik nazoratini takomillashtirish (qoraqolpog ‘iston respublikasi misolida).
6. Saidkasimova, N. S., & Mirtazaev, O. M. (2020). Epidemic Process of Salmonellosis in Tashkent. Indian Journal of Forensic Medicine & Toxicology, 14(4).
7. Миртазаев, О. М., Саидкасимова, Н. С., Матназарова, Г. С., & Хатамов, А. (2022). характеристика проявления эпидемического процесса сальмонеллёза. Results of National Scientific Research International Journal, 1(2), 18-31.
8. Миртазаев, О. М., Матназарова, Г. С., & Магзумов, Х. Б. (2023). ЗООНОЗНЫЙ САЛЬМОНЕЛЛЁЗ-БОЛЕЗНЬ ЦИВИЛИЗАЦИИ. «МИКРОБИОЛОГИЯНИНГ ДОЛЗАРБ МУАММОЛАРИ» МАВЗУСИДАГИ РЕСПУБЛИКА ИЛМИЙ-АМАЛИЙ АНЖУМАНИ, 132.
9. Sattarova, N. A., Mirtazaev, O. M., & Saidkasimova, N. S. (2009). Modern problems of epidemiological process of Salmonelloses in Uzbekistan. Вестник Санкт-Петербургской государственной медицинской академии им. ИИ Мечникова, (2), 193-194.
10. Khamzaeva, N., Matnazarova, G., & Saidkasimova, N. (2024). CORONAVIRUS IN THE REPUBLIC OF UZBEKISTAN DURING 2020-2024 RETROSPECTIVE EPIDEMIOLOGICAL ANALYSIS OF THE DISEASE (TASHKENT CITY AS AN EXAMPLE). Collection of scientific papers «SCIENTIA», (October 25, 2024; Antwerp, Belgium), 258-260.
11. Mirtazayev, O. M., & Saidkasimova, N. S. (2016). Modern aspects of the epidemiology of salmonellosis in the Republic of Uzbekistan. Infection, Immunity, Pharmacology, (7), 103-106.
12. Mirtazayev, О. М., Briko, N. I., Matnazarova, G. S., & Saidkasimova, N. S. (2019). Scientific, methodological and organizational bases of management of the epidemic process in case of salmonellous infection in Uzbekistan. Central Asian Journal of Medicine, 4, 72-80.
13. Саттарова, Н. А., Миртазаев, О. М., Камилов, Д. Ю., Аглиулина, С., & Якубова, Ф. (2011). Характеристика эпидемического процесса сальмонеллезов в г. Ташкенте. Ташкент. Вестник ТМА, 2, 102-104.
14. Абдугопуров, Э., Саидкасимова, Н., & Мавлянов, Д. (2025). Сел ва сув тошқинлари натижасида юзага келувчи эпидемиологик вазиятларда юқумли касалликларнинг аҳоли орасида тарқалишини олдини олиш. Наука и инновации в интересах национального и глобального развития, 1(1), 68-79.
15. Саидкасимова, Н. С., Миртазаев, О. М., & Миртазаева, Н. А. (2020). Социальные факторы, влияющие на заболеваемость сальмонеллезами в Узбекистане. In Школа эпидемиологов: теоретические и прикладные аспекты эпидемиологии (pp. 63-65).
16. Хамзаева, Н. Т., Матназарова, Г. С., Саидкасимова, Н. С., & Абдукаххарова, М. Ф. (2024). ТОШКЕНТ ШАҲРИДА 2020-2023 ЙИЛЛАР МОБАЙНИДА КОРОНАВИРУС COVID-19 ИНФЕКЦИЯСИ БИЛАН КАСАЛЛАНИШНИНГ РЕТРОСПЕКТИВ ЭПИДЕМИОЛОГИК ТАҲЛИЛИ.
17. Matnazarova, G. S., Xamzaeva, N. T., Saidkasimova, N. S., Kurbaniyazova, M. O., & Madenbayeva, G. I. (2024). TOShKENT ShAHRIDA 5-11 YoShDAGI BOLALARDA COVID-19 INFEKSIYaSINING OLDINI OLIShDA BNT162B2 (Pfizer–BioNTech) VAKSINASINING SAMARADORLIGI.
18. Саидкасимова, Н. С., Матназарова, Г. С., Хамзаева, Н. Т., & Жуманиязова, М. К. (2024). ПРОЯВЛЕНИЕ ЭПИДЕМИЧЕСКОГО ПРОЦЕССА САЛЬМОНЕЛЛЁЗНОЙ ИНФЕКЦИИ В УЗБЕКИСТАНЕ.
19. Кенжаева, М. А., Матназарова, Г. С., Саидкасимова, Н. С., & НТ, Х. (2024). Оценка современных эпидемиологических особенностей шигеллёза.
20. Gulbaxor, M., & Nargiza, S. (2024). EPIDEMIOLOGICAL CHARACTERISTICS OF THE INCIDENCE OF SHIGELLOSIS IN THE CITY OF TASHKENT. Central Asian Research Journal for Interdisciplinary Studies (CARJIS), 1(2), 65-71.
21. Bozio CH, Blain A, MacNeil J, Retchless A, Weil LM, Wang X, et al. Meningococcal disease surveillance in men who have sex with men—United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 2018;67:1060–3. https://doi.org/10.15585/mmwr.mm6738a4
22. Folaranmi TA, Kretz CB, Kamiya H, MacNeil JR, Whaley MJ, Blain A, et al. Increased risk for meningococcal disease among men who have sex with men in the United States, 2012–2015. Clin Infect Dis. 2017;65:756–63. https://doi.org/ 10.1093/cid/cix438
23. Kava CM, Rohraff DM, Wallace B, Mendoza-Alonzo JL, Currie DW, Munsey AE, et al. Epidemiologic features of the monkeypox outbreak and the public health response— United States, May 17–October 6, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1449–56. https://doi.org/10.15585/ mmwr.mm7145a4
24. Blackburn D, Roth NM, Gold JAW, Pao LZ, Olansky E, Torrone EA, et al. Epidemiologic and clinical features of mpox in transgender and gender-diverse adults—United States, May–November 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1605–9. https://doi.org/10.15585/ mmwr.mm715152a1
25. Centers for Disease Control and Prevention. Mpox: 2022 U.S. map & case count [cited 2022 Dec 27]. https://www.cdc. gov/poxvirus/mpox/response/2022/us-map.html
